Ernest Hymel,MD,PhD,MBA
Board Certified
Radiation Oncology
Danny Chow, MD
Board Certified
Radiation Oncology
Chisa Echendu, MD,PhD
Radiation Oncology
Harry Smith, MD
Board Certified
Medical Oncology
Sohail Akbani, MD
Board Certified
Medical Oncology
Tahir Naqvi,MD,MBA
Board Certified
Hematology/Oncology
Lindsey Brown, AGACNP-BC
Board Certified
Adult Gerontology Acute Care
Ashley Humphreys, AGACNP-BC
Board Certified
Adult Gerontology Acute Care
Amanda Huang, APRN, FNP-BC
Board Certified
Family Nurse Practitioner
Our dedicated team works together to develop individualized treatment plans
designed to address each patient’s specific healthcare needs. Baptist Regional Cancer
Network is able to provide the most comprehensive treatment program for
patients because of its diverse team of professionals.
Your generosity makes a difference in the lives of Baptist patients in your area.
8333 9th Avenue
Port Arthur
409-729-8088
310 N. 11 Street
Beaumont
409-981-5510
3555 Stagg Drive
Beaumont
409-212-5922
Copyright 2020 Baptist Hospitals of Southeast Texas Regional Cancer Network. All Rights Reserved.
Current trials open at Baptist Regional Cancer Network:
A011401-BWEL: Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
NRG-GI004- Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer
ICARE-Registry-Inherited CAncer REgistry (ICARE) Initiative is to provide individuals interested in participating in studies focused on inherited cancer predisposition the opportunity to enroll in a research registry
To learn more about these studies, you can find the protocols at https://clinicaltrials.gov/ or you may contact Research Coordinator Telice Meadows at 409-212-5979.
Primary Investigator:
Ernest Hymel, MD, PhD, MBA (Radiation Oncology)
Investigators:
Sohail Akbani, MD (Medical Oncology/Hematology)
Tahir Naqvi, MD, MBA (Medical Oncology/Hematology)
Harry Smith, MD (Medical Oncology/Hematology)
Jason Matherne, MD (Pathology)
Research Staff
Telice Meadows, RN, OCN (Clinical Research Manager)